Eli Lilly and Company to Drop Insulin Costs 40% in the US
FDA Approves Abbott’s Epic Plus for Aortic Valve Disease
Pfizer Launches Trial of COVID-19 Treatment for Post-Exposure
AstraZeneca Invests in VaxEquity for saRNA Therapeutics Platform
Improving Adult Vaccination Rates, Health Outcomes Globally
Roche’s Tecentriq Benefits Non-Small Cell Lung Cancer Patients
SAS, UNC-Chapel Hill to Transform Antiviral Drug Development
Thermo Fisher Launches System to Scale Gene Therapy Workflows
COVID-19 Treatment Remdesivir Reduces Hospitalizations by 87%
AbbVie Helps to Advance Gene Therapy for Chronic Retinal Diseases
FDA Authorizes Booster Dose of Pfizer, BioNTech COVID-19 Vaccine
FDA Approves First Biosimilar to Treat Macular Degeneration
Thermo Fisher Launches Enzyme Analyzers for Assay Applications
Second Dose of J&J’s COVID-19 Vaccine 94% Effective
J&J’s Ebola Vaccine Generates Robust Antibody Responses
FDA Grants Breakthrough Designation for Eli Lilly’s Diabetes Drug
Pfizer, BioNTech COVID-19 Vaccine Effective in Pediatric Patients
Providers Hopeful of Immunotherapy to Treat Early-Stage Cancer
Pharma Companies Challenge Federal Plans to Lower Drug Pricing
Resilience to Manufacture mRNA for Moderna’s COVID-19 Vaccine
FDA Accepts Novartis BLA for Monoclonal Antibody in ESCC
Roche Acquires TIB Molbiol to Boost Molecular Diagnostics Profile
Thermo Fisher Launches Portfolio to Advance Quantitative Analysis
Sanofi Inks $1.9B Pharma Acquisition Deal with Kadmon Holdings
Pfizer Initiates Phase 3 Clinical Trial of RSV Vaccine in Adults
Medidata, Labcorp Collaborate to Boost Digital Biomarker Discovery
Moderna, ILCM to Develop mRNA Therapeutic for Ultra-Rare Disease
Biden Administration Unveils Plan to Lower Prescription Drug Prices
3 Use Cases for Real World Evidence in Pharma Drug Development
Eli Lilly’s Jardiance Reduces Death for Heart Failure Patients
FDA Approves Johnson & Johnson’s Schizophrenia Injectable
Novartis Boosts Access to Cholesterol-Lowering RNA Therapy
Premier, Top Health Systems Acquire Exela to Combat Drug Shortages
Thermo Fisher, AstraZeneca to Develop NGS-Based Targeted Therapies
Moderna Submits Initial Data to FDA for COVID-19 Vaccine Booster
Cardiovascular Disease Clinical Trials Still Lack Diversity
Eli Lilly, Lycia Collaborate to Discover Targeted Drug Candidates
Top Manufacturers of Most Prescribed Drugs in Medicare
AMA, APhA, ASHP Call for Immediate End to Ivermectin for COVID-19
Pfizer, BioNTech COVID-19 Vaccine Expands to Latin America
FDA Approves Vivistim System for Chronic Ischemic Stroke
Merck’s Pneumococcal Vaccine Meets Key Endpoints in Phase 3 Trial